Financial Architects, Inc Exact Sciences Corp Transaction History

Financial Architects, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$72.92 - $102.01 $3,646 - $5,100	-50 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $289,564 - $381,859	-3,235 Reduced 98.48%	50 $6,000
Q3 2018 Oct 29, 2018	SELL	$48.29 - $80.6 $74,125 - $123,720	-1,535 Reduced 31.85%	3,285 $259,000
Q2 2018 Aug 03, 2018	SELL	$37.84 - $69.96 $77,572 - $143,418	-2,050 Reduced 29.84%	4,820 $288,000
Q1 2018 Apr 23, 2018	BUY	$39.82 - $57.53 $71,875 - $103,841	1,805 Added 35.64%	6,870 $277,000
Q4 2017 Feb 12, 2018	BUY	$46.49 - $60.51 $73,919 - $96,210	1,590 Added 45.76%	5,065 $266,000
Q3 2017 Nov 01, 2017	BUY	$37.05 - $47.12 $115,781 - $147,250	3,125 Added 892.86%	3,475 $164,000
Q3 2017 Oct 23, 2017	BUY	$37.05 - $47.12 $12,967 - $16,492	350	350 $16,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.